Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics

The upcoming report from TransMedics (TMDX) is expected to reveal quarterly earnings of $0.29 per share, indicating a decline of 17.1$123.56 million, representing an increase of 27.6% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's earnings disclosure, it ...